The Electronic Health Record and Electronic Medical Record Features That Get Built First Are Rarely the Ones Clinicians Actually Need

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

There is a consistent pattern in how electronic health record systems get prioritized during development that has played out across enough implementations to count as a structural problem rather than an isolated one. The features that move fastest through the development queue are the ones that are easiest to define in a requirements document, the […]

The post The Electronic Health Record and Electronic Medical Record Features That Get Built First Are Rarely the Ones Clinicians Actually Need appeared first on Medical News Bulletin.

What’s the latest with cannabis and schizophrenia?

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Does cannabis trigger schizophrenia? Scientists are getting closer to an answer. For years, researchers have debated whether cannabis causes psychosis, or whether people heading for schizophrenia are simply drawn to cannabis first. Now, since Canada legalized cannabis in 2018, we’ve been able to collect better data, and epidemiologists are edging closer to figuring out how […]

The post What’s the latest with cannabis and schizophrenia? appeared first on Medical News Bulletin.

RFK Jr. fires vice chairs of USPSTF

HHS Secretary Robert F. Kennedy Jr. has fired both vice chairs of the U.S. Preventive Services Task Force, according to letters obtained by Healio.
The vice chairs were Esa M. Davis, MD, MPH, FAAFP, a professor at the University of Maryland School of Medicine, and John B. Wong, MD, MACP, a professor at Tufts University School of Medicine.
According to the task force’s website, Davis was appointed vice chair in March 2025. She previously served as a member from January 2021 to December 2024. Wong was appointed vice chair in March 2024. He previously served as a member from March 2018 to December

Yoga improves mood, anxiety, fatigue, sleep in cancer survivors

CHICAGO — A low- to moderate-intensity yoga program performed over 4 weeks significantly improved mood disturbance, anxiety and fatigue among cancer survivors.
The data, presented at ASCO Annual Meeting, also showed that decreased mood disturbance and fatigue had a direct impact on improvements in insomnia.
“You get four bangs for your buck,” Karen M. Mustian, PhD, MPH, professor in the department of surgery at University of Rochester Medicine and associate director for population science at Wilmot Cancer Institute, told Healio. “This is a huge impact for something that lasts about a month.”

Younger age, isolated ACL reconstruction increased graft failure

PHOENIX — Results presented here showed patients younger than 25 years and isolated ACL reconstruction were independent risk factors for graft failure among patients with ACL instability.
“This study is going to continue building on a lot of the momentum that we have seen in the literature and, also, based on the recent consensus statement we came out with last year regarding the use of [lateral extra-articular procedure] in our young pivoting athletes, especially those younger than 25,” Matthew C. Daggett, DO, MBA, of the Scientific Anterior Cruciate Ligament Network International Study

GLP-1s may help prevent metastatic progression of cancer

CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual Meeting.
A database analysis of individuals diagnosed with stage I to stage III cancers showed those who used GLP-1 medications had lower risk for developing metastatic disease than those who used dipeptidyl peptidase-4 (DPP-4) inhibitors.
The protective effects for four malignancies — breast, colorectal, liver and lung cancers — reached statistical significance, with risk reductions ranging from 31% to 50%.
Researchers also

Haven’t applied AI in practice yet? ‘Play with it in everyday life first’

Doctors who have not yet started using AI tools should first get comfortable using them in everyday life before adopting them in clinical practice.
That is the advice from optometrist Scott A. Edmonds, OD, FAAO, a member of the Healio AI Advisory Board who has been using AI in various areas of his practice.
“You learn to use the tool in a much less stressful environment,” Edmonds said. “You learn how the model works and how it thinks. ... Then when I go to use it in the real world, in the clinic, I’m more attuned. I’m not afraid of it. I know what to ask it.
“Play with it in everyday life first,

Biovance 3L offers fast healing, efficient surgery

MIAMI — In this video from Sunshine Eye & Retina, Neel R. Desai, MD, discusses the benefits of decellularized basement membrane.
Desai said Biovance 3L (DefEYE) amniotic membrane offers fast healing while allowing for shorter procedure times and positive outcomes for patients.
{{VIDEO}}
“I think this deserves its own unique category because of its tissue processing,” Desai told Healio. “Decellularized membrane uniquely is just the bioactive basement membrane of the amnion. It is triple layered in Biovance 3L, so we have this purified scaffold for healing and wound coverage that provides for

Beneath the Surface: How to properly apply and use sunscreen

Sunscreen is one of the primary interventions for limiting the harmful effects of ultraviolet radiation, such as skin cancer. However, if applied incorrectly, users will not receive these protective benefits.
In this Beneath the Surface video interview, Joel M. Gelfand, MD, MSCE, FAAD, the James J. Leyden Professor of Clinical Investigation and professor of dermatology and epidemiology at University of Pennsylvania’s Perelman School of Medicine and Healio Dermatology’s Chief Medical Editor, spoke with Adewole S. Adamson, MD, MPP, a dermatologist and health services researcher at Dell Medical

Foslevadopa/foscarbidopa saved resources in Parkinson’s

Treatment with subcutaneous foslevodopa/foscarbidopa was associated with cost savings of more than €95,000, or about $110,000,per patient with advanced Parkinson’s disease over 5 years, according to findings in the Journal of Medical Economics.
“The costs associated with advanced Parkinson's disease extend beyond direct medical expenditure,” K. Ray Chaudhuri, MD, professor of neurology/movement disorders at King’s College Hospital, and colleagues, wrote. “As symptoms become more severe, professional and informal personal care costs are likely to exceed those incurred for medical and